<unk> , sold under the brand name Qulipta, is a medication used to treat migraines. It is a gepant, an orally active calcitonin gene-related peptide receptor (CGRPR) antagonist. It was approved for medical use in the United States in September 2021.
Atogepant
Seltorexant
Bocasan
Almorexant
Befetupitant
Icatibant
Suvorexant
Fosaprepitant